Microfluidic Chip Market Size, Growth, Share and Forecast 2032

Market Overview

Microfluidic Chip Market size was valued at USD 6,256.01 million in 2018 to USD 10,456.50 million in 2024 and is anticipated to reach USD 21,437.59 million by 2032, at a CAGR of 8.75% during the forecast period.

The Microfluidic Chip Market is driven by the increasing demand for rapid, accurate, and cost-effective diagnostic solutions across healthcare, pharmaceutical, and biotechnology sectors. Growing adoption of point-of-care testing and lab-on-a-chip technologies supports the need for miniaturized and integrated systems capable of performing complex analyses with minimal sample volumes. Rising investments in drug discovery, personalized medicine, and life sciences research further accelerate market growth. Technological advancements in microfabrication, including polymer-based chip development and 3D printing, enhance production efficiency and application versatility. The market also benefits from the expansion of genomics and proteomics research, where microfluidics enables high-throughput screening and automation. Additionally, government initiatives promoting early disease detection and the integration of AI and IoT in diagnostic platforms contribute to the growing adoption of microfluidic chips. These trends collectively position microfluidic technologies as essential tools in modern diagnostics, fostering innovation and enabling faster clinical and research outcomes.

The Microfluidic Chip Market shows strong geographical presence across North America, Europe, and Asia Pacific, with each region contributing to distinct areas of growth and innovation. North America leads in technological advancements and R&D funding, driven by established healthcare infrastructure and key industry players. Europe emphasizes regulatory compliance and sustainable design, supporting market expansion through academic-industrial collaborations. Asia Pacific demonstrates the highest growth momentum due to increasing healthcare access, rapid urbanization, and cost-effective manufacturing capabilities, particularly in countries like China, Japan, and India. Key players in the Microfluidic Chip Market include Agilent, known for its broad product portfolio in diagnostics and life sciences; Fluidigm Corporation, recognized for single-cell analysis and genomics applications; and Becton Dickinson, which integrates microfluidics into advanced diagnostic platforms. Danaher also plays a significant role by leveraging its subsidiaries to deliver innovative lab-on-a-chip solutions, strengthening global market presence through strategic acquisitions and product development.

Market Insights

.     The Microfluidic Chip Market was valued at USD 6,256.01 million in 2018, reached USD 10,456.50 million in 2024, and is projected to grow to USD 21,437.59 million by 2032, registering a CAGR of 8.75% during the forecast period.

·       Rising demand for point-of-care diagnostics and personalized medicine is driving adoption of microfluidic chips in clinical and home-based healthcare applications.

·       Trends such as lab-on-a-chip innovation, integration with AI and IoT, and the rise of disposable chip formats are reshaping product development and end-user preferences.

·       Key players like Agilent, Fluidigm Corporation, Becton Dickinson, and Danaher are expanding their global reach through acquisitions, partnerships, and technological advancements.

·       Complex microfabrication processes, high development costs, and lack of uniform regulatory standards continue to challenge rapid commercialization and scalability.

·       North America leads in terms of innovation and infrastructure, while Asia Pacific is witnessing the fastest growth due to rising healthcare investments and manufacturing capabilities.

·       The market is expanding into new applications such as environmental monitoring and food safety testing, creating opportunities beyond the traditional clinical segment.

Market Drivers

Rising Demand for Point-of-Care Diagnostics and Personalized Healthcare Solutions

The Microfluidic Chip Market is gaining momentum due to the expanding use of point-of-care diagnostic tools in both developed and emerging regions. Healthcare providers are prioritizing faster and more accurate diagnostic methods to improve patient outcomes and reduce hospital stays. Microfluidic chips support this shift by enabling compact, efficient, and cost-effective diagnostic platforms. The growing focus on personalized medicine further fuels demand, as these chips allow precise detection of biomarkers and real-time monitoring. Hospitals, diagnostic labs, and home healthcare settings are increasingly adopting microfluidic-based systems. It continues to benefit from rising awareness of early disease detection and the need for decentralized healthcare models.

• For instance, Truenat HPV-HR Plus, a chip-based RT-PCR test, was launched to enable decentralized detection of high-risk human papillomavirus genotypes.

Increasing Integration in Drug Discovery, Genomics, and Proteomics

The use of microfluidic chips in pharmaceutical and biotechnology research is expanding due to their ability to handle small fluid volumes with high accuracy. Drug development workflows benefit from faster screening, reduced reagent usage, and improved control over chemical and biological reactions. Genomics and proteomics applications also rely on these chips for DNA analysis, protein separation, and biomolecule synthesis. The Microfluidic Chip Market is supported by the growing need for high-throughput systems that enable rapid analysis without compromising precision. Research institutions and biotech firms view these chips as essential tools for innovation. It helps reduce cost and complexity in early-stage drug and biomarker discovery.

• For instance, the biotechnology and pharmaceutical industries are utilizing microfluidic chips for drug discovery and development processes.

Advancements in Microfabrication and Materials Technology

Technological improvements in materials science and microfabrication processes are strengthening the capabilities of microfluidic chips. Manufacturers are developing chips with enhanced durability, biocompatibility, and chemical resistance by using advanced polymers, glass, and silicon substrates. Precision molding, soft lithography, and 3D printing are improving design flexibility and scaling potential. The Microfluidic Chip Market is advancing through continuous R&D focused on producing disposable, high-performance devices for clinical and research use. It supports customization based on application-specific requirements, enabling broader adoption across sectors. These advancements reduce barriers to entry for new market participants and encourage device innovation.

Government Support and Growing Adoption in Emerging Economies

Supportive policies, funding programs, and strategic public-private partnerships are driving innovation in microfluidic technology. Governments are investing in point-of-care infrastructure, medical research, and bio-analytical platforms, particularly in countries focused on healthcare modernization. The Microfluidic Chip Market is benefiting from this shift, as funding enables startups and academic institutions to develop scalable solutions. Emerging economies are adopting microfluidic systems to improve diagnostic capabilities in rural and underserved regions. It is becoming central to affordable healthcare strategies, especially where centralized labs are scarce. These factors contribute to a broader and more diverse global market footprint.

Market Trends

Expansion of Lab-on-a-Chip Platforms for Decentralized Testing

The trend toward miniaturized lab-on-a-chip platforms is reshaping diagnostics by enabling decentralized and near-patient testing. These systems integrate multiple laboratory functions onto a single chip, delivering rapid results and improving accessibility in low-resource settings. The Microfluidic Chip Market reflects this transition, with demand rising for portable diagnostic devices in infectious disease testing, environmental monitoring, and veterinary care. It supports timely decision-making in clinical workflows by reducing reliance on centralized laboratories. Companies are focusing on compact designs that combine sample preparation, analysis, and detection in one device. This trend aligns with global health strategies promoting early and widespread diagnostic access.

• For instance, advancements in lab-on-a-chip technologies are driving the demand for point-of-care diagnostics, enabling rapid and accurate testing in remote locations.

Integration of Artificial Intelligence and Internet of Things in Microfluidics

Smart microfluidic systems are gaining traction with the incorporation of artificial intelligence (AI) and Internet of Things (IoT) technologies. AI-powered analytics enhance data interpretation and enable adaptive responses during fluidic processes, while IoT facilitates real-time monitoring and remote operation. The Microfluidic Chip Market is evolving to include these intelligent capabilities, improving automation and reducing the need for manual intervention. It leads to enhanced efficiency in laboratory diagnostics and process control across various industries. Developers are embedding sensors and connectivity modules into chip systems to create self-regulating platforms. This trend is driving product innovation and improving the scalability of microfluidic solutions.

• For instance, AI-driven microfluidic systems are revolutionizing lab-on-a-chip applications by enabling real-time monitoring and adaptive responses.

Growing Application in Environmental and Food Safety Monitoring

Microfluidic technology is extending beyond healthcare into fields such as environmental monitoring and food safety testing. Compact devices offer rapid detection of contaminants, pathogens, and toxins in air, water, and food products. The Microfluidic Chip Market is seeing increased interest from government bodies and regulatory agencies focused on improving public health and safety. It provides a reliable and low-cost solution for on-site testing without complex instrumentation. Industry players are developing chips tailored to field conditions, ensuring accuracy and ease of use. This broadening of application areas is strengthening the market’s versatility and long-term relevance.

Shift Toward Disposable and Single-Use Chip Designs

Demand for disposable and single-use microfluidic chips is increasing across diagnostics, life sciences, and point-of-care testing. These chips minimize cross-contamination risks and simplify compliance with regulatory standards. The Microfluidic Chip Market is incorporating cost-effective materials and scalable manufacturing techniques to support this shift. It enables faster production cycles and reduces operational complexity in laboratories. Manufacturers are focusing on sustainability by using biodegradable or recyclable polymers where possible. This trend supports healthcare systems striving for high-throughput, safe, and environmentally responsible diagnostic practices.

Market Challenges Analysis

Complex Manufacturing Processes and Design Limitations

Designing and fabricating microfluidic chips involves high precision and specialized expertise, which can lead to increased development time and production costs. Small design flaws or material inconsistencies can impact device performance, especially in applications requiring ultra-sensitive detection. The Microfluidic Chip Market faces challenges in achieving scalability while maintaining consistency across large volumes of chips. It depends on advanced microfabrication techniques that are not easily accessible to all manufacturers, particularly startups and small enterprises. Integration of multiple functionalities on a single chip further complicates design, leading to technical hurdles in prototyping and testing. These issues limit rapid deployment and widespread commercialization in cost-sensitive markets.

• For instance, various microfluidic chip fabrication techniques, including soft lithography and laser ablation, present trade-offs in cost, scalability, and material compatibility, affecting mass production efficiency.

Regulatory Hurdles and Standardization Gaps Across Applications

Microfluidic devices often operate in highly regulated sectors like healthcare, pharmaceuticals, and environmental testing, where compliance with safety and performance standards is critical. The Microfluidic Chip Market must address the lack of uniform regulatory frameworks and testing protocols across regions and application areas. It creates barriers to market entry, delays product approvals, and increases compliance costs for manufacturers. Limited standardization also complicates interoperability with existing diagnostic platforms and laboratory equipment. These challenges reduce flexibility for developers aiming to create multi-application or globally deployable solutions. Streamlining regulatory processes and improving cross-border harmonization remain essential for sustained market growth.

Market Opportunities

Emerging Demand in Personalized Medicine and Cancer Diagnostics Advancements in molecular diagnostics and precision medicine are opening new avenues for microfluidic applications in oncology and personalized treatment planning. Microfluidic chips enable efficient analysis of blood, tissue, and genetic samples, supporting non-invasive liquid biopsy and real-time monitoring of treatment response. The Microfluidic Chip Market holds strong potential to address rising global cancer rates and the shift toward tailored therapies. It supports fast and accurate detection of disease-specific biomarkers, improving diagnostic accuracy and treatment outcomes. Hospitals and research institutions are investing in microfluidic platforms to streamline workflows and reduce reliance on centralized labs. These developments create long-term opportunities for chip makers to align with evolving clinical needs.

Expanding Role in Resource-Limited and Decentralized Healthcare Settings

Low-cost, portable microfluidic devices offer significant advantages for rural and underserved areas with limited access to traditional diagnostic infrastructure. The Microfluidic Chip Market can play a key role in supporting global health initiatives focused on equitable healthcare access. It enables rapid diagnosis of infectious diseases such as tuberculosis, HIV, and malaria at the point of care, without needing complex equipment or trained personnel. Governments and non-profit organizations are funding field-deployable diagnostic tools, creating a favorable environment for market expansion. Opportunities lie in developing affordable, rugged, and easy-to-use chips tailored for challenging conditions. These applications support disease control efforts and strengthen healthcare resilience in remote regions.

Market Segmentation Analysis:

By Material Type:

Polymers hold the largest share in the Microfluidic Chip Market due to their low cost, flexibility, and ease of mass production. It supports applications requiring disposable chips, especially in point-of-care diagnostics and clinical testing. Glass materials offer superior chemical resistance and optical clarity, making them suitable for analytical applications and fluorescence-based detection. Silicon chips deliver high precision and thermal conductivity, often used in advanced research and semiconductor-integrated systems. Paper-based microfluidic chips are emerging as low-cost solutions for resource-limited settings, offering simple fabrication and eco-friendly disposal. Each material caters to specific functional demands, shaping market diversification and innovation strategies.

By Functionality: Active microfluidic chips dominate in applications that require external control mechanisms, such as pumps or valves, for precise fluid manipulation. These chips are essential in automated laboratories and high-throughput screening where accuracy and repeatability are critical. Passive microfluidic chips, which rely on capillary action and fluid dynamics without external forces, are gaining traction for cost-sensitive and portable diagnostic systems. The Microfluidic Chip Market benefits from the growing need for both precision-driven and simplified platforms, enabling tailored solutions for a wide range of diagnostic and analytical tasks. It encourages manufacturers to innovate across both functionality types to meet diverse industry requirements.

By Technology: Droplet-based microfluidics is widely used in applications involving single-cell analysis, digital PCR, and high-throughput screening due to its ability to handle discrete fluid volumes with high accuracy. Continuous flow microfluidics supports real-time analysis and controlled chemical reactions, finding strong demand in drug development and biochemical synthesis. Paper-based microfluidics is expanding in low-resource diagnostics, driven by affordability and ease of deployment in field settings. Hybrid microfluidics combines the advantages of multiple platforms to improve system integration and functionality. The Microfluidic Chip Market is expanding across these technologies by addressing varied end-user needs, from complex research environments to point-of-care applications. It provides a flexible foundation for next-generation diagnostic and analytical solutions.

Segments:

Based on Material Type:

• Polymers
• Glass
• Silicon
• Paper

Based on Functionality:

• Active Microfluidic Chips
• Passive Microfluidic Chips

Based on Technology:

• Droplet-Based Microfluidics
• Continuous Flow Microfluidics
• Paper-Based Microfluidics
• Hybrid Microfluidics

Based on Application:

• Clinical Diagnostics
• Environmental Testing
• Drug Development
• Genomics
• Point-of-Care Testing

Based on the Geography:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Russia
  • Belgium
  • Netherlands
  • Austria
  • Sweden
  • Poland
  • Denmark
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Thailand
  • Indonesia
  • Vietnam
  • Malaysia
  • Philippines
  • Taiwan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Peru
  • Chile
  • Colombia
  • Rest of Latin America
• Middle East
  • UAE
  • KSA
  • Israel
  • Turkey
  • Iran
  • Rest of Middle East
• Africa
  • Egypt
  • Nigeria
  • Algeria
  • Morocco
  • Rest of Africa

Regional Analysis

North America Microfluidic Chip Market

North America Microfluidic Chip Market grew from USD 2,096.42 million in 2018 to USD 3,456.61 million in 2024 and is projected to reach USD 7,112.35 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.8%. North America is holding a 33% market share. The region benefits from a strong presence of key players, advanced healthcare infrastructure, and high R&D investments in biotechnology and diagnostics. The United States dominates the regional market, driven by widespread adoption of point-of-care devices and growing use of lab-on-a-chip technologies in research labs. Canada also contributes to growth, with increased focus on decentralized diagnostics and government funding in life sciences. It continues to lead global adoption due to early technology acceptance and continuous innovation.

Europe Microfluidic Chip Market

Europe Microfluidic Chip Market grew from USD 1,936.07 million in 2018 to USD 3,129.07 million in 2024 and is projected to reach USD 6,072.13 million by 2032, at a CAGR of 8.0%. Europe is holding a 28% market share. Strong demand for advanced diagnostic systems in Germany, France, and the UK supports market expansion. The region benefits from collaborative academic-industry research programs and high regulatory standards that ensure device quality and performance. Countries like the Netherlands and Sweden are emerging as innovation hubs, promoting next-generation microfluidic technologies. It maintains steady growth by aligning with healthcare digitization trends and sustainable development initiatives.

Asia Pacific Microfluidic Chip Market

Asia Pacific Microfluidic Chip Market grew from USD 1,653.43 million in 2018 to USD 2,932.32 million in 2024 and is projected to reach USD 6,604.27 million by 2032, at a CAGR of 10.0%. Asia Pacific holds a 31% market share. Rapid urbanization, growing healthcare access, and rising investments in diagnostics are driving the market in China, Japan, South Korea, and India. The presence of manufacturing hubs and cost-effective production facilities enhances regional competitiveness. Government programs focused on infectious disease control and personalized healthcare are further promoting microfluidic adoption. It leads in terms of growth potential and manufacturing scale.

Latin America Microfluidic Chip Market

Latin America Microfluidic Chip Market grew from USD 265.12 million in 2018 to USD 437.00 million in 2024 and is projected to reach USD 781.01 million by 2032, with a CAGR of 6.9%. Latin America holds a 4% market share. Brazil and Mexico are key contributors, supported by expanding private healthcare sectors and increasing diagnostic needs. Regional growth is supported by public health initiatives aimed at early disease detection. Limited access to centralized labs in rural areas is encouraging adoption of portable diagnostic platforms. It offers opportunities for companies targeting low-cost, high-efficiency testing solutions.

Middle East Microfluidic Chip Market

Middle East Microfluidic Chip Market grew from USD 165.47 million in 2018 to USD 251.41 million in 2024 and is projected to reach USD 429.68 million by 2032, at a CAGR of 6.3%. The Middle East holds a 2% market share. The UAE and Saudi Arabia are leading adoption due to rising investments in healthcare infrastructure and digital diagnostics. Governments are focusing on diversifying economies through healthcare innovation, which supports technology implementation. It is gaining attention in laboratory automation and personalized diagnostics, although price sensitivity remains a challenge in broader adoption.

Africa Microfluidic Chip Market Africa Microfluidic Chip Market grew from USD 139.49 million in 2018 to USD 250.10 million in 2024 and is projected to reach USD 438.14 million by 2032, reflecting a CAGR of 6.6%. Africa accounts for a 2% market share. The region is adopting microfluidic solutions for low-resource diagnostic testing, particularly in South Africa, Nigeria, and Kenya. Support from global health organizations and NGOs is enhancing deployment in infectious disease control. Limited laboratory infrastructure creates demand for portable, easy-to-use testing devices. It holds promise for long-term growth driven by healthcare access expansion and international funding.

Key Player Analysis

• Agilent
• Fluidigm Corporation
• Micralyne
• Becton Dickinson
• Danaher
• PerkinElmer
• Bio-Rad Laboratories
• Dolomite
• MicroLIQUID
• MicruX Technologies
• Micronit
• Fluigent

Competitive Analysis

The competitive landscape of the Microfluidic Chip Market is characterized by continuous innovation, strategic partnerships, and strong global distribution networks. Leading players such as Agilent, Fluidigm Corporation, Micralyne, Becton Dickinson, Danaher, PerkinElmer, Bio-Rad Laboratories, Dolomite, MicroLIQUID, MicruX Technologies, Micronit, and Fluigent are actively investing in product development and technological advancements to strengthen their market positions. These companies focus on expanding their application portfolios across clinical diagnostics, genomics, drug discovery, and environmental testing. Companies operating in this space focus on developing advanced lab-on-a-chip systems that cater to diverse applications, including clinical diagnostics, drug discovery, and environmental monitoring. Innovation remains central, with firms emphasizing the integration of AI, IoT, and automation into microfluidic platforms to enhance precision and usability. Competitors prioritize product differentiation through custom design capabilities, high-throughput performance, and ease of integration into existing laboratory workflows. Strategic acquisitions and partnerships with research institutions and healthcare providers play a crucial role in expanding technological capabilities and market access. Several players are also investing in scalable manufacturing and sustainable materials to address cost-efficiency and regulatory compliance. Firms that offer end-to-end solutions, from chip fabrication to data analytics, are gaining a competitive edge. The market is witnessing increasing demand for portable, disposable, and single-use microfluidic devices, encouraging players to adapt their production strategies. A strong intellectual property portfolio, global distribution channels, and domain-specific expertise are essential to remain competitive in this rapidly evolving market.

Recent Developments

• In 2025, bioMérieux (France) acquired SpinChip Diagnostics ASA (Norway) to expand its point-of-care diagnostics portfolio.

• In 2024, BD (US) launched BD MiniDraw (Capillary Blood Collection System) which gives results from only six drops of blood, thus simplifying the whole process.

• In 2024, Illumina. Inc. (US) acquired Fluent BioSciences (US) to enhance its ability for single-cell analysis.

• In 2023, Danaher Corporation (US) acquired Abcam plc (UK) to expand its reach in the proteomics field.

• In 2023, Thermo Fisher Scientific (US) acquired MarqMetrix (US) to enhance its spectroscopy portfolio.

Market Concentration & Characteristics

The Microfluidic Chip Market is moderately concentrated, with a mix of well-established players and emerging innovators competing across global and regional levels. It features a strong presence of specialized manufacturers with proprietary technologies and high entry barriers due to complex design, regulatory compliance, and advanced fabrication requirements. The market is characterized by rapid technological evolution, short product life cycles, and a strong focus on customization. Companies differentiate through application-specific solutions, integrated systems, and strategic collaborations with research institutions. It demands high precision, scalability, and cost-efficiency, making innovation and quality control critical success factors. The market also shows increasing movement toward disposable and portable formats, reflecting the need for point-of-care accessibility and sustainability. Strong R&D investments, patent portfolios, and flexible manufacturing capabilities define the competitive edge, while regional growth dynamics vary based on healthcare infrastructure and investment in diagnostics.

Report Coverage

The research report offers an in-depth analysis based on Material Type, Functionality, Technology, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. The market is projected to experience robust growth, driven by the increasing demand for point-of-care diagnostics and personalized medicine.
2. Advancements in microfabrication techniques are expected to enhance the precision and scalability of microfluidic devices, facilitating their adoption in various applications.
3. Integration of microfluidic chips with artificial intelligence and Internet of Things technologies will likely improve automation and real-time data analysis capabilities.
4. The development of cost-effective and disposable microfluidic devices is anticipated to expand their use in resource-limited settings and emerging markets.
5. Expansion into non-traditional applications, such as environmental monitoring and food safety testing, will diversify the market's reach.
6. Collaborations between industry players and academic institutions are expected to accelerate innovation and the development of novel microfluidic solutions.
7. Regulatory advancements and standardization efforts will play a crucial role in facilitating the commercialization and adoption of microfluidic technologies.
8. The rise of telemedicine and remote patient monitoring will drive the demand for portable and user-friendly microfluidic diagnostic devices.
9. Investments in research and development will continue to be a key factor in maintaining competitive advantage and addressing emerging healthcare challenges.
10. Overall, the Microfluidic Chip Market is poised for significant growth, with technological innovations and expanding applications paving the way for its evolution.

Adoption of Point-of-Care Diagnostics and Personalized Medicine

Healthcare providers are increasingly utilizing microfluidic chips for rapid, accurate, and decentralized diagnostic solutions, supporting the shift toward personalized medicine and early disease detection. This trend is expanding the use of microfluidic chips in both clinical and home-based healthcare settings.

Integration in Drug Discovery, Genomics, and Proteomics

Microfluidic chips enable high-throughput screening, precise biomolecule analysis, and reduced reagent consumption, making them essential in pharmaceutical R&D, genomics, and proteomics. Their ability to handle small sample volumes accelerates innovation in drug discovery and life sciences research.

Advancements in Microfabrication and Materials Technology

Ongoing improvements in microfabrication techniques, such as 3D printing and advanced polymer development, are enhancing the performance, scalability, and cost-effectiveness of microfluidic chips. These advancements support the production of disposable and application-specific devices, broadening market adoption.

Government Support and Healthcare Modernization in Emerging Economies

Public funding, supportive policies, and healthcare infrastructure investments in emerging markets are driving the adoption of microfluidic chips, particularly for decentralized diagnostics in resource-limited settings. This government backing is enabling broader access to advanced diagnostic technologies.

Expansion into Environmental and Food Safety Applications

Microfluidic chips are increasingly being used for rapid, on-site detection of contaminants and pathogens in environmental and food safety testing. This diversification beyond traditional healthcare applications is opening new growth avenues for the market.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.